T. Rowe Price Associates »

Apogee Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $45M 758k 58.74
2024-06-30 $30M 768k 39.35
2024-03-31 $78M 1.2M 66.45
2023-12-31 $22M 771k 27.94
2023-09-30 $13M 616k 21.30

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Rtw Investments
Driehaus Capital Management
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners

View all funds holding Apogee Therapeutics